Advance Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Buy |
3,319
+5
| +0.2% | +$928 | 0.03% | 94 |
|
|
2025
Q1 | $694K | Sell |
3,314
-4
| -0.1% | -$838 | 0.03% | 80 |
|
|
2024
Q4 | $590K | Buy |
3,318
+66
| +2% | +$11.7K | 0.03% | 81 |
|
|
2024
Q3 | $642K | Buy |
3,252
+513
| +19% | +$101K | 0.03% | 79 |
|
|
2024
Q2 | $470K | Sell |
2,739
-163
| -6% | -$28K | 0.02% | 91 |
|
|
2024
Q1 | $528K | Buy |
2,902
+48
| +2% | +$8.74K | 0.04% | 82 |
|
|
2023
Q4 | $442K | Sell |
2,854
-141
| -5% | -$21.8K | 0.03% | 74 |
|
|
2023
Q3 | $446K | Buy |
2,995
+403
| +16% | +$60.1K | 0.04% | 72 |
|
|
2023
Q2 | $349K | Buy |
2,592
+815
| +46% | +$110K | 0.04% | 81 |
|
|
2023
Q1 | $283K | Buy |
1,777
+1
| +0.1% | +$159 | 0.05% | 84 |
|
|
2022
Q4 | $287K | Sell |
1,776
-140
| -7% | -$22.6K | 0.04% | 82 |
|
|
2022
Q3 | $257K | Buy |
1,916
+228
| +14% | +$30.6K | 0.03% | 73 |
|
|
2022
Q2 | $259K | Buy |
1,688
+4
| +0.2% | +$614 | 0.03% | 68 |
|
|
2022
Q1 | $273K | Buy |
1,684
+75
| +5% | +$12.2K | 0.03% | 69 |
|
|
2021
Q4 | $218K | Buy |
+1,609
| New | +$218K | 0.04% | 80 |
|